BackEucrates Biomedical Acquisition - Warrants (23/10/2027) Overview

Eucrates Biomedical Acquisition - Warrants (23/10/2027) Total Assets

Latest total assets for EUCRW: $12M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$12.49M
↓ 88.12% YoYΔ $-92.62M vs prior year quarter

Peer average

Loading

Eucrates Biomedical Acquisition - Warrants (23/10/2027) Total Assets History

Loading

Eucrates Biomedical Acquisition - Warrants (23/10/2027) vs. peers: Total Assets Comparison

Loading

Eucrates Biomedical Acquisition - Warrants (23/10/2027) Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Eucrates Biomedical Acquisition - Warrants (23/10/2027) (EUCRW) FAQ

As of the most recent data (December 2022), EUCRW shows a total assets of $12M. That compares with $110M in the prior-year period — down 88.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, EUCRW's total assets is now $12M (was $110M) — a 88.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Eucrates Biomedical Acquisition - Warrants (23/10/2027) is outperforming or lagging.

Tracking EUCRW's total assets over time shows whether Eucrates Biomedical Acquisition - Warrants (23/10/2027) is scaling, shrinking, or reshaping that part of the business. The current reading is $12M That compares with $110M in the prior-year period — down 88.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Eucrates Biomedical Acquisition - Warrants (23/10/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $12M) with ownership activity and broader fundamentals.